April 09, 2019

Prapela about to release SVS in its “next generation” baby box soon

Today, April 9th, the US Patent and Trademark Office (USPTO) issued the first patent for Prapela’s infant health-promoting technology. The first Stochastic Vibrotactile Stimulation (SVS) technology patent applies to reducing infant irritability and crying related to colic and neonatal abstinence syndrome (NAS).

SVS is a gentle, random vibration that is sleep-cycle friendly and non-habit forming.
Clinical studies demonstrate SVS can enhance the rhythmicity of infant breathing and improve relaxation. Prapela, Inc. exclusively licensed SVS for infant health from Harvard’s Office of Technology Development (OTD) and has since improved quality and reduced the cost of SVS products.

Colic is when babies experience crying or fussiness for 3 hours or more a day, for 3 days of the week or more over a 3 week period. Up to 20% of all infants experience colic. It most often occurs between 4 and 6 weeks of age and usually stops when a baby reaches 4 months of age. No one really knows what causes colic. However, many physicians and experts believe it is a reaction to food making a baby’s stomach feel uncomfortable.

Neonatal Abstinence Syndrome (NAS) is what newborns experience as they withdraw from the opioids taken by their mothers during pregnancy. NAS babies are hyperirritable and the most prevalent condition they experience is irregular breathing. About 50,000 newborns will be diagnosed this year with NAS and treating these babies is a significant burden on caregivers in hospitals and at home.

Doctors recommend soothing colicky babies and newborns with NAS with skin to skin contact, snuggling, swaddling and caring for them in a dark, quiet room. Prapela’s SVS is a new tool to complement these proven techniques. Prapela's SVS baby box is for home use to help calm a fussy baby and provides a safe sleep environment. The Prapela SVS hospital bassinet pad to treat NAS symptoms in hospitals is not available for commercial sale pending regulatory clearance.

Previously, Prapela’s SVS Baby Box took top honors in the “Next Gen Baby Box Quickfire Challenge” held in Helsinki, Finland and sponsored by Johnson & Johnson, Janssen and the Finnish Innovation Fund. The SVS hospital bassinet pad was recently awarded a Phase 1 grant from the NIH/National Institute on Drug Abuse (NIDA). Last month at SXSW, Prapela was an award winner at the Impact PediatricHealth Competition.

Prapela is working to make its SVS Baby Box available this Spring.

Stay In Touch